Oslo, 19 September 2025 - Observe Medical ASA (OSE: OBSRV) ("the Company" or "Observe Medical") will host a presentation with trading update Tuesday, 7 October 2025.

Observe Medical invites investors, analysts, and other stakeholders to the presentation which will take place virtually Tuesday 7 October 2025, at 09:00 CET, and streamed via webcast at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20251007_1/

Please note that this is a postponement of the previously announced presentation scheduled for 23 September, to allow the Company to incorporate the recent investment agreement with Songa Capital AS and affiliated, included in relevant documents as previously announced.

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.